Metabolic imaging by positron emission tomography in oncology.
Positron emission tomography (PET) is a novel method in nuclear medicine to image metabolism in vivo. A wide range of physiological tracers labelled with positron emitters are available for dynamic measurements of various physiological and pathological functions of the body. PET is nowadays widely used for cardiological and neurological studies in health and disease. Oncological applications are under eager investigations. In particular, the detection of viable residual and recurrent tumour is a difficult clinical challenge which is expected to be solved by PET, while the altered metabolism related to cancer can also be studied.
Leskinen
S
S
Department of Oncology and Radiotherapy and Turku Medical Cyclotron/PET Centre, University Central Hospital, Finland.
Lapela
M
M
Lindholm
P
P
Minn
H
H
D001932:Brain Neoplasms / Q000000981:diagnostic imaging; D019788:Fluorodeoxyglucose F18; D006258:Head and Neck Neoplasms / Q000000981:diagnostic imaging; D006801:Humans; D008175:Lung Neoplasms / Q000000981:diagnostic imaging; D009369:Neoplasms / Q000000981:diagnostic imaging* / Q000378:metabolism*; D011859:Radiography; D014055:Tomography, Emission-Computed
D019788:Fluorodeoxyglucose F18